article Open AccessTop 1% cited
Integrative Genomic Profiling of Human Prostate Cancer
Cancer Cell · 2010 · Vol. 18(1) · pp. 11–22
Barry S. Taylor(Memorial Sloan Kettering Cancer Center)Nikolaus Schultz(Memorial Sloan Kettering Cancer Center)Haley Hieronymus(Memorial Sloan Kettering Cancer Center)Anuradha Gopalan(Memorial Sloan Kettering Cancer Center)Yonghong Xiao(Memorial Sloan Kettering Cancer Center)Brett S. Carver(Memorial Sloan Kettering Cancer Center)Vivek Arora(Memorial Sloan Kettering Cancer Center)Poorvi Kaushik(Memorial Sloan Kettering Cancer Center)Ethan Cerami(Memorial Sloan Kettering Cancer Center)Boris Reva(Memorial Sloan Kettering Cancer Center)Yevgeniy Antipin(Memorial Sloan Kettering Cancer Center)Nicholas Mitsiades(Memorial Sloan Kettering Cancer Center)Thomas Landers(Memorial Sloan Kettering Cancer Center)Igor Dolgalev(Memorial Sloan Kettering Cancer Center)John E. Major(Memorial Sloan Kettering Cancer Center)Manda Wilson(Memorial Sloan Kettering Cancer Center)Nicholas D. Socci(Memorial Sloan Kettering Cancer Center)Alex Lash(Memorial Sloan Kettering Cancer Center)Adriana Heguy(Memorial Sloan Kettering Cancer Center)James A. Eastham(Memorial Sloan Kettering Cancer Center)Howard I. Scher(Memorial Sloan Kettering Cancer Center)Victor E. Reuter(Memorial Sloan Kettering Cancer Center)Peter T. Scardino(Memorial Sloan Kettering Cancer Center)Chris Sander(Memorial Sloan Kettering Cancer Center)Charles L. Sawyers✉(Memorial Sloan Kettering Cancer Center)William L. Gerald(Memorial Sloan Kettering Cancer Center)
Prostate Cancer Treatment and ResearchCancer Genomics and DiagnosticsCancer-related molecular mechanisms researchProstate cancerChromoplexyBiologyTMPRSS2ProstateCancer researchDiseaseCancerOncogeneAndrogen receptor
MeSH terms
AdultAgedAged, 80 and overAnimalsChromosomes, Human, Pair 3HumansMaleMiddle AgedNeoplasm MetastasisProstatic NeoplasmsTransplantation, HeterologousTumor Cells, CulturedBiomarkers, TumorSignal TransductionOncogene Proteins, Fusion
Funding
- Howard Hughes Medical Institute
- Memorial Sloan-Kettering Cancer Center
Citations
3,759
FWCI
148.88
field-weighted impact
References
63
Percentile
100%
vs. same field & year
Citations per year
Cited by
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
Oncogene · 2013 · 861 citations
The landscape of long noncoding RNAs in the human transcriptome
Nature Genetics · 2015 · 2,873 citations
Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer
Nature Structural & Molecular Biology · 2013 · 545 citations
References
Molecular determinants of resistance to antiandrogen therapy
Nature Medicine · 2003 · 2,266 citations
A Novel Human Prostate-Specific, Androgen-Regulated Homeobox Gene (NKX3.1) That Maps to 8p21, a Region Frequently Deleted in Prostate Cancer
Genomics · 1997 · 358 citations
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
New England Journal of Medicine · 2004 · 6,318 citations
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 106,483 citations
Gene expression correlates of clinical prostate cancer behavior
Cancer Cell · 2002 · 2,523 citations
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
New England Journal of Medicine · 2002 · 6,503 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.